AirFit™ P10
At just 1.6 oz,1 AirFit™ P10 combines lightweight comfort, quiet performance and a secure seal5 in a minimalist design built to help patients start therapy and stay on it. AirFit™ P10 for Her offers the same proven performance in a design tailored for women.
Confidence built over a decade.
For more than a decade, providers have relied on AirFit™ P10 to help patients start therapy and stay on it. Today, strong compliance outcomes and HME validation continue to reinforce its position as the benchmark in nasal pillows masks.
1
Weighing only 1.6oz1 with just three components supports comfort, simplicity and ease of use from day one.
2
Dual-wall nasal pillows are designed to deliver lower leak rates than the average for pillows masks,5 helping support more consistent therapy.
3
QuickFit™ headgear simplifies fitting and adjustment with minimal setup.
4
QuietAir™ venting diffuses exhaled air at 20dBA6 to help reduce disturbances for patients and their bed partners.
The same performance. Designed for her.
AirFit™ P10 for Her offers the same lightweight comfort, secure seal and quiet performance in a design tailored for women.
References
- Source: Resmed internal verification testing conducted from July-August of 2017.
- Source: Data are derived from an analysis of new PAP therapy patients in the United States using AirView™ and myAir™ platforms. Patients were included if myAir™ setup occurred from 7 days before through 14 days after the AirView™ setup date (i.e., −7 to +14 days) and valid mask data were available. Compliance (90-day) was assessed for setups between January 2024 and December 2024. Compliance was defined as PAP use for ≥4 hours per night on ≥70% of nights during any consecutive 30-day period within the first 90 days of therapy, with the AirView™ setup date counted as day 1. Days to compliance represents the number of days from AirView™ setup until the first date the patient achieved compliance. Analysis included the top 45 mask models, representing 99.8% of mask selections among new users in myAir™. Days to compliance (90th percentile) is the number of days from AirView™ setup by which 90% of patients achieved compliance. Overall average = 41.7 days mean across the 45 included mask models; n = 557,021. AirFit P10 = 39 days, n = 65,796.
- Source: Based on an online, double-blinded survey of 92 U.S.-based HME providers conducted by Peel Research Partners, Dec 12–22, 2025.
- Source: Leading nasal pillows masks selected based on Resmed analysis of U.S. market data as of June 2026. Masks reviewed: F&P Nova Micro, F&P Solo Pillows, Philips DreamWear Pillows, React Health Rio II, and AirFit P10. Comparison based on manufacturer-published user-guide sound power declarations and Resmed objective bench testing comparing AirFit P10 and F&P Nova Micro Pillows under flow-normalised conditions (approx. 33 L/min).
- Source: Data are derived from an analysis of U.S. PAP therapy patients using AirView™ and myAir platforms. Patients were included based on registration within ±14 days of AirView setup and valid mask data. Compliance was assessed for 2024 setups (n = 557,021; AirFit™ P10 n = 65,796), and 1-year adherence for 2023 setups (n = 389,270; AirFit™ P10 n = 50,156). Compliance was defined as PAP use for ≥4 hours per night on ≥70% of nights during any consecutive 30-day period within the first 90 days of therapy. AirFit™ P10 demonstrated lower leak rates than the average for pillows masks (median 1.9 vs. 2.2 L/min; 95th percentile 12.0 vs. 12.7 L/min). No statistical significance testing was performed.
- Source: Resmed internal verification testing conducted June 2026.